639 related articles for article (PubMed ID: 15005850)
1. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
[TBL] [Abstract][Full Text] [Related]
2. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys.
Burr DB; Hirano T; Turner CH; Hotchkiss C; Brommage R; Hock JM
J Bone Miner Res; 2001 Jan; 16(1):157-65. PubMed ID: 11149480
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
Chen P; Jerome CP; Burr DB; Turner CH; Ma YL; Rana A; Sato M
J Bone Miner Res; 2007 Jun; 22(6):841-8. PubMed ID: 17352652
[TBL] [Abstract][Full Text] [Related]
4. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY
J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques.
Sato M; Westmore M; Clendenon J; Smith S; Hannum B; Zeng GQ; Brommage R; Turner CH
Osteoporos Int; 2000; 11(10):871-80. PubMed ID: 11199192
[TBL] [Abstract][Full Text] [Related]
6. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
Sato M; Zeng GQ; Turner CH
Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
[TBL] [Abstract][Full Text] [Related]
7. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
8. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Jerome CP; Burr DB; Van Bibber T; Hock JM; Brommage R
Bone; 2001 Feb; 28(2):150-9. PubMed ID: 11182372
[TBL] [Abstract][Full Text] [Related]
9. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
Fox J; Miller MA; Recker RR; Turner CH; Smith SY
Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
[TBL] [Abstract][Full Text] [Related]
10. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
[TBL] [Abstract][Full Text] [Related]
12. Effects of single and concurrent intermittent administration of human PTH (1-34) and incadronate on cancellous and cortical bone of femoral neck in ovariectomized rats.
Zhang L; Endo N; Yamamoto N; Tanizawa T; Takahashi HE
Tohoku J Exp Med; 1998 Oct; 186(2):131-41. PubMed ID: 10223616
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.
Valenta A; Roschger P; Fratzl-Zelman N; Kostenuik PJ; Dunstan CR; Fratzl P; Klaushofer K
Bone; 2005 Jul; 37(1):87-95. PubMed ID: 15869920
[TBL] [Abstract][Full Text] [Related]
14. Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)].
Vahle JL; Zuehlke U; Schmidt A; Westmore M; Chen P; Sato M
J Bone Miner Res; 2008 Dec; 23(12):2033-9. PubMed ID: 18684088
[TBL] [Abstract][Full Text] [Related]
15. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
[TBL] [Abstract][Full Text] [Related]
16. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
[TBL] [Abstract][Full Text] [Related]
17. Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates.
Seeherman HJ; Li XJ; Smith E; Parkington J; Li R; Wozney JM
J Bone Joint Surg Am; 2013 Jan; 95(1):36-47. PubMed ID: 23283371
[TBL] [Abstract][Full Text] [Related]
18. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
Wang L; Orhii PB; Banu J; Kalu DN
Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
[TBL] [Abstract][Full Text] [Related]
19. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
Iwamoto J; Seki A; Sato Y
Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
[TBL] [Abstract][Full Text] [Related]
20. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
Kostenuik PJ; Smith SY; Jolette J; Schroeder J; Pyrah I; Ominsky MS
Bone; 2011 Aug; 49(2):151-61. PubMed ID: 21457806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]